#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    X-linked lymphoproliferative syndrome Oesophageal achalasia Systemic lupus erythematosus Rheumatoid arthritis Gastrooesophageal cancer Pyoderma gangrenosum Hepatoblastoma Autoinflammation with infantile enterocolitis Cutaneous T-cell lymphoma stage II Fms-like tyrosine kinase 3 positive Acute respiratory distress syndrome Burkitt's lymphoma refractory Wiskott-Aldrich syndrome Acute myeloid leukaemia (in remission) Von Willebrand's disease More trials…

    Learn about Rare Diseases

    Alternating hemiplegia of childhood – Life with Disease Crigler-Najjar syndrome – Diagnostics Propionic acidaemia – Basic Information Osteosarcoma – Trials in Disease Leiomyosarcoma recurrent – Basic Information Metachromatic leukodystrophy Vascular malformation Progressive multifocal leukoencephalopathy – Life with Disease Angiosarcoma non-metastatic – Life with Disease Primary hyperoxaluria – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-6194 Sodium Dexamethasone Hyoscine Butylbromide Bi 1839100 CC-97540 Cln-081 ZUNIBERGENE ROCPARVOVEC Promazine Hydrochloride Medroxyprogesterone Acetate Human Coagulation Factor Vii Tilmanocept Tranexamic Acid Indacaterol Maleate Aflibercept Taldefgrobep Alfa Tpst-1120 Aaa802 Tetrahydrouridine ARGININE GLUTAMATE More therapies…

    Learn about Your Condition

    Insulin resistance Myositis Iron deficiency Factor VIII deficiency Diabetic foot Hernia repair T-cell lymphoma Tuberculosis Cerebrovascular accident Giant cell arteritis Colonoscopy Metastases to meninges Haemorrhagic stroke Underweight Multiple sclerosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Axial spondyloarthritis

  • Study on Upadacitinib for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1
    Investigated Drugs:
    • Abt-494
    Belgium Bulgaria Czechia France Germany Hungary +3

  • Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Croatia Czechia Estonia France +9

  • Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bimekizumab
    Belgium Czechia France Germany Hungary Poland +1
Previous Page
1 2 3 4

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!